M Holdings Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,370
Closed -$310K 551
2022
Q4
$296K Sell
4,370
-200
-4% -$11.7K 0.03% 340
2022
Q3
$228K Sell
4,570
-330
-7% -$17.7K 0.03% 375
2022
Q2
$273K Sell
4,900
-92
-2% -$5.11K 0.03% 360
2022
Q1
$277K Buy
+4,992
New +$256K 0.02% 411
2014
Q4
Sell
-3,000
Closed -$71K 349
2014
Q3
$71K Buy
+3,000
New +$69K 0.04% 340

Other funds holding NVO

M Holdings Securities's NVO Position: Q1 2023 in Review

M Holdings Securities sold out of Novo Nordisk (NVO) in Q1 2023, closing a stake of 4,370 shares — an estimated $310K sold.

M Holdings Securities first reported a position in NVO in Q3 2014 and held it in 5 quarters. The position peaked at $296K in Q4 2022. 1,146 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • M Holdings Securities reported no remaining Novo Nordisk position as of Q1 2023 after selling out during the quarter.
  • M Holdings Securities sold 4,370 Novo Nordisk shares in Q1 2023, an estimated $310K.
  • M Holdings Securities first reported a position in Novo Nordisk in Q3 2014 and held it in 5 quarters.
  • M Holdings Securities's Novo Nordisk position peaked at $296K in Q4 2022.
  • 1,146 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on M Holdings Securities's 13F filing for Q1 2023, filed 16 May 2023.